This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTION: Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway

TL;DR
This retracted study claimed that combining aloin and metformin could fight liver cancer by affecting specific cell pathways, but errors and image duplication invalidated the findings.
Contribution
The paper was retracted due to significant data errors and image duplication, invalidating its novel claim about the antitumor effects of aloin and metformin in liver cancer.
Findings
The study was retracted due to significant data collection and analysis errors.
Image duplication was found in figures, compromising the paper's conclusions.
The authors could not support the original claims about the PI3K/AKT/mTOR pathway effects.
Abstract
RETRACTION: R. Sun, R. Zhai, C. Ma, and W. Miao, “Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway,” Cancer Medicine 9, no. 3 (2020): 1141–1151, https://doi.org/10.1002/cam4.2723. The above article, published online on 12 December 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor‐in‐Chief, Stephen Tait; and John Wiley and Sons Ltd. The authors asked to retract the article as they found significant errors in the data collection and analysis, therefore the conclusions of the paper are not supported. Subsequently, an investigation into concerns raised by a third party revealed inappropriate duplication of images (Figure 1C, 2B and 4C, D) between this and other…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAutophagy in Disease and Therapy · Cancer-related molecular mechanisms research · Peroxisome Proliferator-Activated Receptors
** RETRACTION:** R. Sun, R. Zhai, C. Ma, and W. Miao, “Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway,” Cancer Medicine 9, no. 3 (2020): 1141–1151, https://doi.org/10.1002/cam4.2723.
The above article, published online on 12 December 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor‐in‐Chief, Stephen Tait; and John Wiley and Sons Ltd. The authors asked to retract the article as they found significant errors in the data collection and analysis, therefore the conclusions of the paper are not supported. Subsequently, an investigation into concerns raised by a third party revealed inappropriate duplication of images (Figure 1C, 2B and 4C, D) between this and other articles that were previously published or published shortly after in a different scientific context. Thus, the editors consider the conclusions of this manuscript substantially compromised. Although the authors initially asked for the retraction, when asked to approve the retraction wording, they remained unresponsive.
